Welcome to our dedicated page for Acacia Resh news (Ticker: ACTG), a resource for investors and traders seeking the latest updates and insights on Acacia Resh stock.
Acacia Research Corp (ACTG) delivers strategic value through patent licensing expertise and technology-driven acquisitions. This news hub provides investors and professionals with essential updates on intellectual property developments, operational milestones, and financial performance.
Access timely press releases covering patent portfolio monetization, industrial sector acquisitions, and partnership announcements. Our curated news collection enables users to track ACTG's progress in transforming underutilized assets into revenue-generating opportunities across multiple industries.
Key content categories include earnings reports, licensing agreements, strategic investments, and management updates. Each update is selected for its relevance to understanding the company's dual focus on IP commercialization and diversified business operations.
Bookmark this page for direct access to verified information about ACTG's activities in technology commercialization and value-driven acquisitions. Regularly updated to reflect the company's latest moves in patent licensing markets and operational expansions.
Acacia Research Corporation (NASDAQ: ACTG) will release its first quarter 2022 financial results before market open on May 12, 2022. A conference call is scheduled for the same day at 11:00 a.m. ET to discuss the results. Interested parties can access the live call by dialing 888-506-0062 for the U.S. or 973-528-0011 internationally, using access code 199065. The call will also be webcasted on the company’s website, with a replay available for 30 days.
Acacia Research Corporation (ACTG) reported strong financial results for the full year 2021, generating $149.2 million in net income, equating to $1.91 per diluted share. This performance was fueled by $76.0 million in revenue from its Intellectual Property segment and $116.1 million in realized gains primarily from its Life Sciences Portfolio. The company completed the acquisition of Printronix for $33 million, contributing $12.0 million to revenues. In 2022, it anticipates revenues between $13.0 million and $14.0 million for Q1, with a new $40 million stock repurchase program approved.
Acacia Research Corporation (NASDAQ: ACTG) will release its fourth quarter and year-end 2021 financial results on March 31, 2022, before the market opens. A conference call to discuss these results is scheduled for 11:00 a.m. ET. Interested parties can access the call by dialing 888-506-0062 in the U.S. or 973-528-0011 internationally. The call will also be webcast on Acacia's investor relations website. Acacia focuses on acquiring undervalued businesses, leveraging flexible capital and operational expertise across various sectors.
Acacia Research Corporation (NASDAQ: ACTG) has announced significant leadership changes, appointing Martin D. McNulty, Jr. as Chief Operating Officer and Head of M&A, and promoting Wesley L. Golby to Chief Investment Officer. McNulty brings extensive M&A experience, notably from his previous role at Starboard Value Acquisition Corp., where he led a $3.4 billion transaction. Golby has been with Acacia since August 2020, contributing to the acquisition strategy. These appointments are expected to enhance Acacia's operational capabilities and support its growth strategy.
Outerbridge Capital Management has voiced concerns over
Outerbridge Capital Management announced that Institutional Shareholder Services (ISS) supports the election of nominees Sidney Fuchs and Wendi Carpenter to Comtech's Board of Directors, urging shareholders to vote on the WHITE proxy card.
ISS criticized Comtech's poor financial performance and questioned the board's commitment to meaningful change. The board's decision to pursue financing options without thorough exploration was flagged. The upcoming vote is set for December 17, 2021, emphasizing the need for independent voices in response to an acquisition offer from Acacia Research Corp (NASDAQ: ACTG).
Acacia Research reported significant financial developments for Q3 2021, highlighted by a nearly $120 million gain from the IPO of Oxford Nanopore. Pro forma book value increased to $6.31 per share, while cash and investments soared to $605.1 million. Gross revenue was $1.6 million, a decline from $19.5 million year-over-year, and the operating loss grew to $12.7 million. Notably, net income surged to $80.2 million or $0.86 per diluted share, compared to $29.2 million or $0.32 per share last year. A conference call is scheduled for November 15, 2021.
Acacia Research Corporation (NASDAQ: ACTG) has announced that its subsidiary, Atlas Global Technologies LLC, has granted a license to Samsung Electronics, resolving previous patent litigation. This is the first licensing deal for Atlas Global's Wi-Fi 6 standard essential patents, reflecting the strength of its portfolio. The financial terms of the agreement remain confidential. Acacia specializes in acquiring undervalued businesses and leveraging unique capabilities to create value in mature technology sectors.
Acacia Research Corporation (NASDAQ: ACTG) will release its third quarter financial results after market close on November 15, 2021. A conference call to discuss the results is scheduled for 4:30 p.m. ET on the same day. Interested parties can join the call by dialing 888-506-0062 for U.S. participants or 973-528-0011 for international callers. The call will also be webcasted on Acacia's investor relations website, with a replay available for 30 days post-event.
Outerbridge Capital Management, holding approximately 4.9% of Comtech Telecommunications Corp. (CMTL), has urged for greater shareholder representation on the board amid reports of Acacia Research Corporation's (ACTG) $30 per share acquisition offer. Outerbridge claims the current board lacks the necessary expertise for a proper evaluation of this strategic option and urges the appointment of three independent nominees to ensure a fair assessment. They highlight recent concerns over a dilutive equity transaction that could jeopardize shareholder value.